Education
About Us
Working with TipRanks
Follow Us
Takeda Pharmaceutical Company (TAK)
NYSE:TAK
Active Comparator, Zasocitinib
Psoriatic Arthritis
Phase III
Recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Oct 31, 2024
―
Dexamethasone, Pembrolizumab, Tocilizumab, Tak-500
Breast Cancer, Pancreatic Cancer, Gastric Cancer, Esophageal Cancer, Hepatocellular Cancer, Squamous Cell Cancer Of Head And Neck (Scchn), Non-Small Cell Lung Cancer (Nsclc), Non-Squamous, Nasopharyngeal Cancer, Kidney Cancer, Mesothelioma
Phase I/II
Terminated
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Sep 24, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Takeda Pharmaceutical Company (TAK) have in its pipeline
TAK is currently developing the following drugs: Tak-861, Mezagitamab, Tak-411. These drug candidates are in various stages of clinical development as the company works toward FDA approval.